CoQ10 for Heart Health
TL;DR
CoQ10 has been studied as a complementary (adjunctive) option alongside standard care for people with heart failure. Landmark trials and recent meta-analyses show it may support improved symptoms, reduced hospitalisations, and better functional measures when added to conventional therapy. It is not a standalone treatment and should never replace prescribed medication. Evidence rating: ⭐⭐⭐⭐ Strong as complementary support.
Evidence Rating: ⭐⭐⭐⭐ Strong (multiple RCTs and meta-analyses of adjunctive use)
What the Research Shows for Heart Health
The heart has extremely high energy demands. CoQ10 is essential for mitochondrial ATP production in cardiac muscle cells and also functions as a lipid-soluble antioxidant. Myocardial CoQ10 levels are often lower in people with more severe heart failure. Research has therefore explored CoQ10 as an adjunctive supplement — taken in addition to standard medical therapy, not instead of it.
Key Benefits (when used as complementary support)
- May support improved heart-failure symptoms and functional capacity (e.g. 6-minute walk distance) when added to standard therapy
- Associated with lower rates of hospitalisation for heart failure in multiple trials
- May support better left ventricular ejection fraction in some studies
- Generally well tolerated with a favourable safety profile in long-term use
Key Studies
- Mortensen S.A. et al. (2014) — Q-SYMBIO trial. Randomised, double-blind, multicentre study of 420 patients with moderate-to-severe chronic heart failure. CoQ10 100 mg three times daily or placebo was added to standard therapy for 2 years. The CoQ10 group showed a significant reduction in major adverse cardiovascular events (15% vs 26%; HR 0.50), lower cardiovascular and all-cause mortality, fewer heart-failure hospitalisations, and improved NYHA class at 2 years. JACC Heart Fail, 2(6), 641–649. DOI: 10.1016/j.jchf.2014.06.008
- Xu J. et al. (2024) — Meta-analysis of 33 randomised controlled trials. When used as adjuvant therapy, CoQ10 was associated with lower all-cause mortality (RR 0.64), reduced hospitalisation for heart failure (RR 0.50), improved left ventricular ejection fraction, better 6-minute walk distance, lower BNP, and improved NYHA classification. No major adverse effects reported. BMC Cardiovasc Disord, 24, 592. DOI: 10.1186/s12872-024-04232-z
Expert Views
Dr. Peter Attia discusses CoQ10 in the context of mitochondrial health and as a potential complementary tool for patients with heart failure or those on certain medications. He emphasises that it is not a primary treatment.
Dr. Rhonda Patrick has covered CoQ10’s role in mitochondrial function and antioxidant defence in her research content.
NZ Context for Heart Health
New Zealand has relatively high rates of cardiovascular disease. Many Kiwis also take statins. CoQ10 is widely available and may be a useful complementary option for some people already under medical care — always under the guidance of a GP or cardiologist.
Recommended Dosage for Heart Support
- Typical studied dose in heart-failure contexts: 200–300 mg per day (often 100 mg three times daily)
- Take with meals containing fat for better absorption
- Ubiquinol form may offer superior bioavailability, especially in older adults; ubiquinone was used in Q-SYMBIO and remains well-studied
Safety Notes
CoQ10 is generally well tolerated. All major positive trials used it alongside conventional medications. It is not a substitute for prescribed treatment. Discuss with your cardiologist or GP before adding any supplement if you have cardiovascular disease or take heart medications.
This is not medical advice. BioHackNZ provides general information based on published research. CoQ10 is a complementary supplement and is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any supplement regimen, particularly if you have cardiovascular disease or take heart medications. Individual results vary.
Last updated: 22 July 2026 | BioHackNZ Research Team
Shop Coenzyme Q10
View Product →